fda semaglutide warning news october 2025 shortage ends as sets deadline for compounders Novo Nordisk expands legal action

In September 2023, the warning label was updated to mention ileus in the Postmarketing Experience section

Cohort Study: Risk of Gallstones and Biliary Complications With Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes

King Law Is Investigating Ozempic Claims Related To Severe Side Effects Allegedly Caused By Ozempic King Law is actively investigating Ozempic claims being brought by people who experienced severe side effects after taking this semaglutide drug

GLP-1s may affect temperature sensitivity through the hypothalamus, the brain region involved in temperature regulation

Research shows semaglutide offers key advantages: greater weight loss, slightly better blood sugar control, weekly (not daily) dosing, and fewer side effects